Can We Protect the Gut in Critical Illness? The Role of Growth Factors and Other Novel Approaches
- 1 July 2010
- journal article
- review article
- Published by Elsevier in Critical Care Clinics
- Vol. 26 (3) , 549-565
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- ERRATUMShock, 2008
- Heparin-binding epidermal growth factor–like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitisJournal of Pediatric Surgery, 2007
- IGF-1 Protects Intestinal Epithelial Cells From Oxidative Stress-Induced ApoptosisJournal of Surgical Research, 2006
- Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in miceBiochemical and Biophysical Research Communications, 2006
- Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in miceBiochemical and Biophysical Research Communications, 2005
- Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel ratsClinical Nutrition, 2001
- Increased Mortality Associated with Growth Hormone Treatment in Critically Ill AdultsNew England Journal of Medicine, 1999
- Why is epidermal growth factor present in the gut lumen?Gut, 1996
- Epidermal growth factor enhances intestinal adaptation after massive small bowel resectionJournal of Pediatric Surgery, 1994